A majority of patients with Type 1 diabetes who were treated with dapagliflozin, a Type 2 diabetes medicine, had a significant decline in their blood sugar levels, according to a new study by a University at Buffalo researcher.
Buffalo's acclaimed professional internationally touring dance company will perform world premieres and more at the Center for the Arts on Friday, October 6th.